NASDAQ: IOVA
Iovance Biotherapeutics Inc Earnings Dates, Reports, Calls

Iovance Biotherapeutics earnings were -$410.0M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest IOVA earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$83.5M, down 14% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, IOVA reported annual earnings of -$444.0M, with 12.2% growth. The next IOVA earnings date is Feb 26, 2025.

IOVA earnings history

Current Revenue
$90.9M
Current Earnings
-$410.0M
Current Profit Margin
-451.3%

IOVA Return on Equity

Current Company
-58.4%
Current Industry
19.9%
Current Market
35%
IOVA's Return on Equity (-58.4%)... subscribe to Premium to read more.
High Return on Equity Performance

IOVA Return on Assets

Current Company
-45.5%
Current Industry
1.3%
IOVA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when IOVA announces earnings.

IOVA Return on Capital Employed

Current Company
-47.66%
Current Industry
14.3%
IOVA's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

IOVA vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
IOVA-$374.51M-$410.00MN/A-$1.49
WVE-$133.83M-$142.52MN/A-$1.11
BCRX-$24.12M-$123.82MN/A-$0.61
GERN-$187.93M-$201.19MN/A-$0.32
BLTE-$31.20M-$31.63MN/A-$1.19

IOVA earnings dates

Next earnings date
Feb 26, 2025

Iovance Biotherapeutics Earnings Reports & History FAQ

What were Iovance Biotherapeutics's earnings last quarter?

On IOVA's earnings call on Invalid Date, Iovance Biotherapeutics (NASDAQ: IOVA) reported Q3 2024 earnings per share (EPS) of -$0.28, up 39.13% year over year. Total IOVA earnings for the quarter were -$83.54 million. In the same quarter last year, Iovance Biotherapeutics's earnings per share (EPS) was -$0.46.

If you're new to stock investing, here's how to buy Iovance Biotherapeutics stock.

When does Iovance Biotherapeutics report earnings?

The next IOVA earnings call is Invalid Date. Add IOVA to your watchlist to be reminded of Iovance Biotherapeutics's next earnings date.

What was IOVA's earnings growth in the past year?

As of Iovance Biotherapeutics's earnings date in Invalid Date, Iovance Biotherapeutics's earnings has grown year over year. IOVA earnings in the past year totalled -$410.00 million.

Is Iovance Biotherapeutics profitable or losing money?

As of the last Iovance Biotherapeutics earnings report, Iovance Biotherapeutics is currently losing money. Iovance Biotherapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$410.00 million, a 5.31% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.